dc.date.accessioned |
2023-03-06T07:33:18Z |
|
dc.date.available |
2023-03-06T07:33:18Z |
|
dc.date.issued |
2022 |
|
dc.identifier.citation |
Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8612-8619. doi: 10.26355/eurrev_202211_30398. |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/100597 |
|
dc.relation.isversionof |
10.26355/eurrev_202211_30398 |
|
dc.relation.isversionof |
10.26355/eurrev_202211_30398 |
|
dc.title |
The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19 |
|
dc.relation.journal |
Eur Rev Med Pharmacol Sci |
|
dc.identifier.doi |
10.26355/eurrev_202211_30398 |
|
dc.contributor.author |
Karacaer C |
|
dc.contributor.author |
Karacaer C |
|
dc.contributor.author |
Sert H |
|
dc.contributor.author |
Demirci T |
|
dc.contributor.author |
Varım C |
|
dc.contributor.author |
Kaya G |
|
dc.contributor.author |
Genc AB |
|
dc.contributor.author |
Ergenc DCH |
|